Aspirin Use in Patients Aged 80 years and over in Turkey: Snapshot of Results from the ASSOS Study

Basit Öğe Kaydı
dc.authorscopusid36562061700
dc.authorscopusid57203388899
dc.authorscopusid55308222200
dc.authorscopusid36472957600
dc.authorscopusid55881069100
dc.authorscopusid57205583309
dc.authorscopusid12775525400
dc.contributor.authorMemiç Sancar K.
dc.contributor.authorÇelik O.
dc.contributor.authorÇil C.
dc.contributor.authorBaşaran Ö.
dc.contributor.authorDemirci E.
dc.contributor.authorOzan Tanık V.
dc.contributor.authorYetim M.
dc.date.accessioned2024-06-12T10:26:35Z
dc.date.available2024-06-12T10:26:35Z
dc.date.issued2022
dc.description.abstractObjectives: Acetylsalicylic acid (aspirin) is commonly used with various indications, especially in the elderly population. This study aims to evaluate the prevalence of polypharmacy and aspirin use in patients aged ?80 years. Methods: The ASSOS trial is a cross-sectional, national registry study. This nonrandomized study was conducted by 30 cardiologists in 14 cities on the elderly (over the age of 80 years) who used aspirin (80–325 mg). Polypharmacy is described as an intake of five or more medicines daily. Results: A total of 309 patients were included in the study, and 146 (47.2%) of them were females. Aspirin treatment for primary prevention (PP) was reported to be given to 101 (32.7%) patients, and polypharmacy was detected in 198 (64.1%) patients. Major gastrointestinal bleeding was reported in 7 (3.5%) patients in the polypharmacy group and 0 (0.0%) patients in the without polypharmacy group (p=0.043). Minor bleeding was reported in 58 (29.3%) patients in the polypharmacy group and in 8 (7.2%) patients in the group without polypharmacy (p<0.001). Conclusion: Aspirin was reported to be used commonly among patients aged ?80 years for PP although the current guidelines do not recommend aspirin for PP in Turkey. Polypharmacy is still critical in the very elderly population and should be carefully considered in terms of complications. Copyright © 2023 Magnolia Press.en_US
dc.description.sponsorshipWe extend our sincere thanks to Assoc. Prof. Serkan Kahraman for his contribution to statistical analysis. We extend our gratitude to Altuğ Ösken, Süleyman Çağan Efe, Buğra Özkan, Vahit Demir, Macit Kalçık, Bülent Özlek, Eda Özlek, Sedat Kalkan, Şıho Hidayet, Özcan Örsçelik, Aysel Gökçek, Emine Altuntaş, Tuncay Kırış, Emrah Kucuk, Abdullah Orhan Demirtaş, Ramazan Asoğlu, Zafer Kucuksu, Onur Aslan, Yunus Celik, Gokay Taylan, and Murat Civan for their contributions.en_US
dc.identifier.doi10.5505/anatoljfm.2022.26566
dc.identifier.endpage84en_US
dc.identifier.issn2630-5593
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85169574008en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage79en_US
dc.identifier.trdizinid1122535en_US
dc.identifier.urihttps://doi.org/10.5505/anatoljfm.2022.26566
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1122535
dc.identifier.urihttps://hdl.handle.net/20.500.14551/16907
dc.identifier.volume5en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherKare Publishingen_US
dc.relation.ispartofAnatolian Journal of Family Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAged; Aspirin; Polypharmacyen_US
dc.titleAspirin Use in Patients Aged 80 years and over in Turkey: Snapshot of Results from the ASSOS Studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu